Venture Capital, AI, and QSBS

a special panel hosted by BluePointe Capital and CANOPY

CANOPY Menlo Park

6 | 20 | 23

4.30 pm – 7.30 pm

RSVP to Attend

FINAL620 VC Flyer 8 × 55 in 2

CANOPY, Allocate, and BluePoint Capital Management present a  discussion around the intersections of venture capital, QSBS, and innovations in Bio and AI as critical drivers of innovation at CANOPY Menlo Park.

During our first panel BluePoint Capital Management CEO, Sanjeev Sardana, will moderate insights on the nuances of QSBS tax treatment and gaining liquidity from private stock and options together with panelists Christopher Karachale, Partner, Hanson Bridgett, and Stephanie Biran, VP, Quid.

Following comments from Steve Mohebi, CANOPY’s CEO and cofounder, we’ll dive into the future of innovation exploring key drivers in Bio & AI.

Allocate CEO Samir Kaji will moderate a conversation with partners from two of the Valley’s most notable venture capital firms: Greg Yap, Partner, Menlo Ventures; Jen Kha, Partner, Andreessen Horowitz; and Jay Rughani, Partner, Bio + Health investing team, Andreessen Horowitz

Seats for this intimate event are limited: RSVP here or email to secure your spot.

We look forward to seeing you there!